+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Enflurane Market by Route of Administration (Inhalation, Oral), End-Use (Ambulatory Surgical Centers, Hospitals) - Forecast 2024-2030- Product Image
Global Enflurane Market by Route of Administration (Inhalation, Oral), End-Use (Ambulatory Surgical Centers, Hospitals) - Forecast 2024-2030- Product Image
Sale

Global Enflurane Market by Route of Administration (Inhalation, Oral), End-Use (Ambulatory Surgical Centers, Hospitals) - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967854
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Enflurane Market size was estimated at USD 206.39 million in 2023, USD 215.70 million in 2024, and is expected to grow at a CAGR of 4.59% to reach USD 282.70 million by 2030.

Enflurane, chemically designated as 2-chloro-1,1,2-trifluoroethyl difluoromethyl ether, is an inhalational anesthetic historically utilized in medicine to induce and maintain general anesthesia. It operates by modulating the activity of various neurotransmitter systems in the central nervous system, leading to a reversible loss of consciousness and sensation. While enflurane was once widely used in surgical settings for its advantageous pharmacokinetic profile, including a moderate onset and duration of action, its application has diminished over time due to the development of newer agents with improved safety and efficacy profiles.

Enflurane's need is driven by the increasing number of surgical interventions worldwide, advancements in medical practices, and significant investments in healthcare infrastructure. Despite facing challenges such as stringent regulatory standards, potential side effects, and competition from newer anesthetics with improved safety profiles, the enflurane market holds promising growth opportunities. These include the exploration of advanced, safer anesthetic formulations with reduced side effects, leveraging technological innovations such as data analytics and AI for precision dosing, and expanding into emerging markets with rising healthcare standards. Research and innovation focusing on eco-friendly alternatives and the potential integration of nanotechnology for targeted drug delivery represent transformative directions for enhancing the market's growth trajectory while addressing environmental concerns and improving patient outcomes.

Regional Insights

In the Americas, enflurane has a significant market driven by robust healthcare infrastructure, high per capita healthcare expenditure, and a strong emphasis on surgical procedures requiring general anesthesia. In the European Union, varying healthcare policies across member states affect enflurane's market penetration. Nations with more significant governmental healthcare spending exhibit higher rates of enflurane utilization in anesthesia protocols. The EMEA region presents a diverse market ranging from oil-rich nations with advanced healthcare facilities to developing economies with limited medical infrastructure. Affordability issues may drive its use in less affluent areas.

In the Asia Pacific, the enflurane market is evolving due to the rapidly expanding healthcare sector and surge in surgical procedures. India's market for enflurane is influenced by its growing healthcare infrastructure, increased accessibility to medical facilities, and cost sensitivity. The balance between affordability and efficacy plays a critical role in enflurane's adoption in the Indian market.

Market Trends by Segment

  • Route of Administration: Increasing administration of enflurane via inhalation
  • End-Use: Evolving usage of enflurane by hospitals

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical

SunMed finalized its acquisition of Vyaire Medical's Respiratory Anesthesia Consumables division. This strategic acquisition positions SunMed at the forefront of the medical supplies sector, enhancing its portfolio with a range of high-quality respiratory anesthesia products previously under Vyaire Medical. This expansion solidifies SunMed's market presence and signals its commitment to providing comprehensive solutions in healthcare, particularly in anesthesia care.

Key Company Profiles

The report delves into recent significant developments in the Enflurane Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Drägerwerk AG & Co. KGaA, GE HealthCare Technologies Inc., Hikma Pharmaceuticals PLC, J&TEC CO., LTD., and Sanofi S.A.

This research report offers invaluable insights into various crucial aspects of the Enflurane Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of chronic diseases and accidents globally
5.1.1.2. Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
5.1.2. Restraints
5.1.2.1. Emergence of newer and advanced anesthetic agents
5.1.3. Opportunities
5.1.3.1. Technological innovations in anesthesia delivery and monitoring techniques
5.1.3.2. Ongoing research into biodegradable, eco-friendly alternatives
5.1.4. Challenges
5.1.4.1. Regulatory scrutiny and stringent guidelines governing the use of enflurane
5.2. Market Segmentation Analysis
5.2.1. Route of Administration: Increasing administration of enflurane via inhalation
5.2.2. End-Use: Evolving usage of enflurane by hospitals
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Enflurane Market, by Route of Administration
6.1. Introduction
6.2. Inhalation
6.3. Oral
7. Enflurane Market, by End-Use
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Hospitals
8. Americas Enflurane Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Enflurane Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Enflurane Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical
11.4. Strategy Analysis & Recommendation
12. Competitive Portfolio
12.1. Key Company Profiles
12.2. Key Product Portfolio
List of Figures
FIGURE 1. ENFLURANE MARKET RESEARCH PROCESS
FIGURE 2. ENFLURANE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENFLURANE MARKET DYNAMICS
FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 20. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ENFLURANE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 20. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 21. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 22. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 23. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 24. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 25. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 26. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 27. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 28. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 29. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 30. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 31. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 32. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 33. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 34. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 35. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 36. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 37. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 38. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 39. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 40. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 41. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 42. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 43. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 44. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 45. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 46. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 48. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 50. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 52. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 53. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 54. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 55. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 56. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 57. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 58. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 59. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 60. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 61. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 62. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 63. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 64. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 65. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 66. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 67. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 70. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 71. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 72. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 73. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 74. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 75. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 76. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 77. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 78. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 79. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 80. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 81. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 82. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 83. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 84. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 85. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 86. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 87. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 88. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 89. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 90. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 91. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 92. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 93. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 94. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 95. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 96. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 97. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 98. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 99. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 100. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 107. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 108. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 109. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 110. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 111. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 112. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 113. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 114. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 115. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 116. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 117. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 118. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 119. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 120. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 121. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 122. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 123. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 124. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 125. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 126. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 127. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 128. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 129. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 130. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 131. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 132. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 133. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 134. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 135. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 136. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 137. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 138. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 139. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 140. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 141. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 142. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 143. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 144. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 145. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 146. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 147. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 148. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 149. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 150. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 151. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 152. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 153. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 154. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 155. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 156. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 157. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 158. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 160. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 162. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 164. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 166. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 167. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 168. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 169. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 170. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 171. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 172. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 173. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 174. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 175. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 176. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 177. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 178. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 179. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 180. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 181. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 182. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 188. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 190. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 191. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • AbbVie Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Drägerwerk AG & Co. KGaA
  • GE HealthCare Technologies Inc.
  • Hikma Pharmaceuticals PLC
  • J&TEC CO., LTD.
  • Sanofi S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 215.7 Million
Forecasted Market Value ( USD ) by 2030 $ 282.7 Million
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Enflurane Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Enflurane Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 83 Pages
  • Global
From
Enflurane (CAS 13838-16-9) Global Market Research Report 2024 - Product Image

Enflurane (CAS 13838-16-9) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Anesthetic Drugs Market by Drug Type (General Anesthesia Drugs, Local Anesthesia Drugs), Route of Administration (Inhalation, Injection), Application - Forecast 2024-2030 - Product Image

Global Anesthetic Drugs Market by Drug Type (General Anesthesia Drugs, Local Anesthesia Drugs), Route of Administration (Inhalation, Injection), Application - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Local Anesthesia Drugs Market by Drug Type (Bupivacaine, Chloroprocaine, Lidocaine), Type (Over-the-Counter, Prescription), Mode of Administration, Distribution Channel, End-Use - Forecast 2024-2030 - Product Image

Global Local Anesthesia Drugs Market by Drug Type (Bupivacaine, Chloroprocaine, Lidocaine), Type (Over-the-Counter, Prescription), Mode of Administration, Distribution Channel, End-Use - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Drug (Sevoflurane, Isoflurane, Desflurane), By Application, By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023-2030 - Product Image

Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Drug (Sevoflurane, Isoflurane, Desflurane), By Application, By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023-2030

  • Report
  • 110 Pages
  • Global
From

About the Market

Enflurane is an inhalational anesthetic drug used in the induction and maintenance of general anesthesia. It is a halogenated ether, and is one of the most widely used volatile anesthetics in the operating room. Enflurane is a non-flammable, non-explosive anesthetic agent with a low blood/gas partition coefficient, allowing for rapid induction and recovery times. It is also known for its low solubility in blood, which reduces the risk of anesthetic awareness. Enflurane is used in a variety of surgical procedures, including cardiac, orthopedic, and neurosurgical operations. It is also used in the treatment of chronic pain, and in the management of acute pain in the emergency room. Enflurane is available in a variety of formulations, including liquid, vaporizer, and aerosol. It is also available in combination with other anesthetic agents, such as nitrous oxide and propofol. Some companies in the Enflurane market include Baxter International, Hospira, Merck, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.